Repagab M is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Neuropathic Pain, Epilepsy.
Medical history of the patient along with age and gender determines the dosage of Repagab M. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Repagab M are Sleepiness, Dizziness, Drowsiness. Normally, these side effects of Repagab M are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Repagab M's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Repagab M's effects on the liver, heart and kidney are discussed below in the Repagab M related warnings section.
The section on Repagab M contraindications lists all such conditions.
Drug reaction of Repagab M with other medicines has been reported. See below for a complete list.
In addition to the above precautions for Repagab M, it is important to know that it is not safe while driving, and is not habit-forming.
Repagab M is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Repagab M safe for pregnant women?
Repagab M may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Repagab M again without your doctor's advice.
Is the use of Repagab M safe during breastfeeding?
Repagab M may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Repagab M, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Repagab M.
What is the effect of Repagab M on the Kidneys?
Repagab M may have mild side effects on the kidneys.
What is the effect of Repagab M on the Liver?
Repagab M is not harmful for the liver.
What is the effect of Repagab M on the Heart?
Repagab M is not harmful for the heart.
Repagab M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Repagab M unless your doctor advises you to do so -
Is this Repagab M habit forming or addictive?
No, you will not get addicted to Repagab M.
Is it safe to drive or operate heavy machinery when consuming?
After taking Repagab M, you should not drive or work on any heavy machine, as Repagab M can make you drowsy.
Is it safe?
Yes, but consume Repagab M only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Repagab M in mental disorders is not effective.
Interaction between Food and Repagab M
You can take Repagab M with food.
Interaction between Alcohol and Repagab M
Consumption of alcohol and Repagab M together may have severe effects on your health.
Yes, Repagab M has been found to be effective against tingling and burning sensations in a leg, and spontaneous pain, associated with diabetic neuropathy.
Repagab M works by forming myelin sheath which is used to cover and protect the nerve cells. Repagab M is used to revive the nerve cells. In the absence of enough Repagab M, myeline sheath doesn't form properly leading to nerve damage.
Yes, there may be some undesirable effects associated with Repagab M such as acne, acne-rosacea (redness of the face) and some allergic reactions.
The Repagab M is susceptible to breaking down in the presence of light and it also gets affected by the moisture. Therefore, it should be consumed as soon as the package is opened and must be protected from the light and moisture.
The general recommended an oral dose of the Repagab M is 1500 µg daily, divided into three doses. It is also available in other forms such as injectibles. Patients with critically low levels of methylcobalamin are often recommended by to take intramuscular injections to cover up for their deficiency.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
Product Description [Internet]: MECOBALAMIN. National Pharmaceutical Regulatory Agency
Package Leaflet [Internet]: PREGABALIN. Accord Healthcare Limited
April Hazard Vallerand, Cynthia A. Sanoski. Davis’s Drug Guide For Nurses. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048
